Company profile for Enliven Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall patient well-being. Enliven’s discovery process combines deep insights from clinically validated biologica...
Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall patient well-being. Enliven’s discovery process combines deep insights from clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
6200 Lookout Road Boulder, CO 80301
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/enliven-therapeutics-announces-new-ceo-to-drive-next-phase-of-development-302638603.html

PR NEWSWIRE
11 Dec 2025

https://www.prnewswire.com/news-releases/enliven-therapeutics-reports-inducement-grants-as-permitted-by-the-nasdaq-listing-rules-302639654.html

PR NEWSWIRE
11 Dec 2025

https://www.prnewswire.com/news-releases/enliven-therapeutics-reports-third-quarter-financial-results-and-provides-a-business-update-302613308.html

PR NEWSWIRE
12 Nov 2025

https://www.prnewswire.com/news-releases/enliven-therapeutics-announces-clinical-data-in-cml-patients-with-atypical-fusion-transcripts-at-ash-2025-annual-meeting-302602610.html

PR NEWSWIRE
03 Nov 2025

https://www.prnewswire.com/news-releases/enliven-therapeutics-announces-oral-and-poster-presentations-at-the-society-of-hematologic-oncology-soho-2025-annual-meeting-302538061.html

PR NEWSWIRE
25 Aug 2025

https://www.prnewswire.com/news-releases/enliven-therapeutics-announces-pricing-of-public-offering-of-common-stock-and-pre-funded-warrants-302481177.html

PR NEWSWIRE
13 Jun 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty